XML 61 R46.htm IDEA: XBRL DOCUMENT v3.22.4
Business Combination - Schedule of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
 7 Months Ended 12 Months Ended
May 24, 2022
Dec. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Business Acquisition [Line Items]          
Total purchase consideration, net of $46,548 cash acquired     $ 999,120 $ 0 $ 0
Liabilities:          
Goodwill   $ 409,049 409,049 $ 0  
Antares Pharma, Inc          
Business Acquisition [Line Items]          
Cash acquired $ 46,548        
Total purchase consideration, net of $46,548 cash acquired 999,120 999,120      
Assets:          
Short-term investments 498 498 498    
Accounts receivable, net 82,160 82,160 82,160    
Inventories, net 34,379 28,068 28,068    
Prepaid expenses and other assets 5,241 5,241 5,241    
Prepaid expenses and other assets 28,661 28,661 28,661    
Intangibles, net 987,500 589,800 589,800    
Liabilities:          
Accounts Payable 7,197 7,197 7,197    
Accrued expenses 33,705 41,654 41,654    
Deferred revenue, current portion 2,509 2,509 2,509    
Deferred revenue, net of current portion 1,207 1,207 1,207    
Deferred tax liabilities, net 159,094 71,002 71,002    
Other long-term liabilities 135,088 20,788 20,788    
Net assets acquired, excluding goodwill 799,639 590,071 590,071    
Goodwill $ 199,481 409,049 $ 409,049    
Measurement period adjustment          
Inventories, net   (6,311)      
Intangibles, net   (397,700)      
Accrued expenses   7,949      
Deferred tax liabilities, net   (88,092)      
Other long-term liabilities   (114,300)      
Net assets acquired, excluding goodwill   (209,568)      
Goodwill   $ 209,568